1. retroroseclothin
2. faria4588
3. Straightshooter
1.Straightshooter 01/25/2018
Wedbush reiterates Outperform rating; PT raised to $59 from $52
2.retroroseclothin 01/31/2018
Oppenheimer raises to outperform
3.retroroseclothin 05/29/2018
Telsey Advisory Group raises PT to $62 from $49
4.retroroseclothin 03/05/2018
Foot Locker, Inc. (FL): Buy the Weakness, Says Canaccord
5.Straightshooter 05/25/2018
CEO Richard Johnson
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW